Armata Pharmaceuticals

OverviewSuggest Edit

Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections. Its main product is AP-SA01 that targets Staphylococcus aureus including multidrug-resistant strains. The company also develops a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals was formed as a result of the merger between C3J Therapeutics and AmpliPhi Biosciences.
TypePublic
Founded2019
HQMarina del Rey, CA, US
Websitearmatapharma.com

Latest Updates

Employees (est.) (Mar 2020)33
Revenue (FY, 2014)$409 K
Share Price (Sept 2021)$3.8(-1%)
Cybersecurity ratingAMore

Key People/Management at Armata Pharmaceuticals

Steve Martin

Steve Martin

Chief Financial Officer
Duane Morris

Duane Morris

Vice President of Operations
Odysseas Kostas

Odysseas Kostas

Director
Robin C. Kramer

Robin C. Kramer

Director
Joseph M. Patti

Joseph M. Patti

Director
Todd C. Peterson

Todd C. Peterson

Director
Show more

Armata Pharmaceuticals Office Locations

Armata Pharmaceuticals has an office in Marina del Rey
Marina del Rey, CA, US (HQ)
4503 Glencoe Ave
Show all (1)

Armata Pharmaceuticals Financials and Metrics

Armata Pharmaceuticals Revenue

Armata Pharmaceuticals's revenue was reported to be $409 k in FY, 2014
USD

Net income (Q1, 2021)

(5.5m)

EBIT (Q1, 2021)

(5.4m)

Market capitalization (17-Sept-2021)

96.0m

Closing stock price (17-Sept-2021)

3.8

Cash (31-Mar-2021)

22.5m

EV

85.9m
Armata Pharmaceuticals's current market capitalization is $96 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

409.0k

General and administrative expense

6.9m6.4m8.4m7.6m5.7m9.3m8.0m

R&D expense

5.8m4.0m5.7m2.9m4.9m9.8m14.4m

Operating expense total

12.7m10.4m14.1m10.5m10.6m19.1m22.4m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

101.0k103.0k102.0k31.0k

General and administrative expense

1.6m2.0m1.7m1.4m1.6m1.6m2.6m2.5m1.8m1.9m2.8m1.6m1.6m1.4m1.3m2.1m2.1m3.8m2.2m2.0m1.8m2.2m

R&D expense

1.0m1.9m1.8m972.0k1.1m728.0k2.0m1.2m1.7m1.5m1.1m1.5m1.7m361.0k1.5m3.1m3.0m2.8m2.6m4.1m4.4m

Operating expense total

2.6m3.8m3.5m2.4m2.7m2.3m4.6m3.7m3.4m3.4m3.9m1.6m3.1m3.1m1.6m3.6m5.2m6.8m4.9m4.6m5.9m6.5m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

6.6m9.4m5.7m5.1m8.2m6.0m9.6m

Accounts Receivable

100.0k125.0k25.0k

Prepaid Expenses

339.0k521.0k619.0k253.0k251.0k622.0k636.0k

Current Assets

7.0m10.0m6.4m5.4m8.4m6.7m10.8m
USDQ1, 2014

Financial Leverage

-1.4 x
Show all financial metrics

Armata Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Armata Pharmaceuticals Online and Social Media Presence

Embed Graph

Armata Pharmaceuticals News and Updates

Armata Pharmaceuticals Announces Chief Executive Officer Transition

MARINA DEL REY, Calif., Aug. 2, 2021 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata," "us," "our," or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial...

Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference

MARINA DEL REY, Calif., July 7, 2021 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Armata Pharmaceuticals Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

NEW YORK, May 13, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Armata Pharmaceuticals Inc. (NYSE American:...

Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs

MARINA DEL REY, Calif., Jan. 27, 2021 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today...

Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors

MARINA DEL REY, Calif., Dec. 9, 2020 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today...

Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development

MARINA DEL REY, Calif., Oct. 26, 2020 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections,...
Show more

Armata Pharmaceuticals Frequently Asked Questions

  • When was Armata Pharmaceuticals founded?

    Armata Pharmaceuticals was founded in 2019.

  • Who are Armata Pharmaceuticals key executives?

    Armata Pharmaceuticals's key executives are Steve Martin, Duane Morris and Odysseas Kostas.

  • How many employees does Armata Pharmaceuticals have?

    Armata Pharmaceuticals has 33 employees.

  • Who are Armata Pharmaceuticals competitors?

    Competitors of Armata Pharmaceuticals include Livzon Pharmaceutical Group, Cipla and PPD.

  • Where is Armata Pharmaceuticals headquarters?

    Armata Pharmaceuticals headquarters is located at 4503 Glencoe Ave, Marina del Rey.

  • Where are Armata Pharmaceuticals offices?

    Armata Pharmaceuticals has an office in Marina del Rey.

  • How many offices does Armata Pharmaceuticals have?

    Armata Pharmaceuticals has 1 office.